Companies Directory

The International Baltic Sea Foundation for Nature Conservation (BaltCF) was established in 2014. Our aim is to protect the unique and fragile ecosystem of the Baltic Sea. We fund a wide variety of conservation projects in the Baltic Sea region and are on our way to develop our own activities to further our mission.

International Bank for Economic Co-operation (IBEC) - multilateral development bank registered with the United Nations Secretariat. IBEC is aimed at promoting the growth and contributing to the development of its member states'​ economies. The Bank's member countries are 8 states representing both Europe and Asia: Bulgaria, Czech Republic, Mongolia, Poland, Romania, Russia, Slovakia and Vietnam. The intergovernmental status of the Bank determines its financial stability and provides additional guarantees to its counterparties. The Bank has Fitch Ratings investment grade rating: long-term BBB- (stable).

IBML is an unlisted Australian-registered mineral exploration and development company, with a primary focus on investing in and operating on gold and copper mines. IBML has a major investment in Macquarie Gold Limited (MGL) and its Challenger Gold Mine in Adelong, New South Wales, Australia. MGL has been constructing facilities capable of handling 100,000 tonnes of ore per annum and producing gold at a rate of 12,000oz to 15,000oz per year from MGLs existing JORC defined resource in the Challenger Deposit. A test run of the crusher unit was carried out successfully in late May 2016 and mining and production are expected to commence in late August 2016. Through IBMLs wholly-owned Namibian subsidiary, Craton Mining and Exploration (Pty) Ltd ('Craton'), IBML holds the Omitiomire copper deposit which contains a resource of almost 750,000 tonnes of contained copper metal. IBML plans a two-stage approach to bring Omitiomire into production: Phase 1 - a modest-sized project based on near-surface oxide copper and mixed oxide-sulphide copper; Phase 2 - a larger project based on the deeper sulphide copper resource. The Company completed a Definitive Feasibility Study for the Phase 1 operation in late 2013 and is awaiting the grant of a Mining Licence. IBML has additional exploration projects in Namibia and Australia.

The International Beauty Institute is the culmination of years of industry experience to bring you the most advanced curriculum available. Our staff is committed to giving you a well-rounded education to guide you to the career you want. A modern International Curriculum shows our commitment to the evolving Aesthetic Industry Standards worldwide. We are always at the pulse of change and innovation in the beauty industry. We currently service Mississauga, Toronto, Etobicoke, Hamilton, Oakville, Burlington, Niagara and all surrounding areas. International Beauty Institute students will gain: Knowledge: Develop a thorough understanding of your Craft and the Industry. Skill: Develop and perfect your techniques. Technology: Work with the most modern cosmetic tools, lasers and aesthetic equipment. Professionalism: Respect for your Client’s Safety and Customer Service Excellence. Confidence: That will set you apart and guarantee your success. Learn with the most modern technologies available. Use the best skin care and make-up products on the market. Develop the most skilled techniques. Perfect your craft alongside experienced instructors in small class sizes. IBI instructors are Medical Aestheticians, Laser Technicians and Make-up Artists ready to assist YOU in achieving your career goals. We offer in-depth programs that provide “real-life” training, preparing you for the career you want! learn about our programs.

The International Biometrics + Identity Association is the leading international trade group representing the identification technology industry. Recognizing the vital role identity plays in a globally connected world, IBIA brings stakeholders into a single organization that provides its members: Advocacy: IBIA is a first line of defense against legislation, regulations, and public misperceptions that frequently threaten to derail business opportunities Connections: Access to decision-makers, empowering them to shape priorities in line with their company's needs Education: Information companies need, including special reports on technology, policy, and regulation, along with business opportunities IBIA's Mission is to advance the adoption and responsible use of technologies for managing human identity to enhance security, privacy, productivity, and convenience for individuals, organizations, and governments. IBIA membership is a hallmark of successful identity management companies, giving customers confidence in their technology and solutions

International Biophysics brings to market innovative, disruptive medical devices and technologies that improve treatment therapies and patient outcomes. Centered on a precision ISO 13485 certified, FDA registered quality controlled manufacturing facility in Austin, Texas, International Biophysics has a 25 year pedigree of successful medical product and technology launches around the globe.  We discover, make and deliver science inspired medical innovation, creating custom pathways to success in multiple markets, spanning direct-from-manufacturer sales to product line and company spin-off acquisitions. For a quarter of a century, we have manufactured products with an unwavering commitment to quality and on-time delivery. Whether molding a component or producing simple surgical tubing organizers and vessel loops or sophisticated products such as erbium lasers, portable oxygen concentrators, HFCWO vests, heart pumps, audiometer machines; we can meet all your requirements. Put International Biophysics'​ capabilities and rigorous quality control to work for you today.

IBT offers investors the opportunity to invest in the growing biotechnology sector, which is creating innovative medicines that treat unmet medical needs and have the potential to produce very attractive long term returns. In the years to 31 August 2013 the NASDAQ Biotechnology Index NBI a representative index for the biotech sector outperformed the S&P 500 by 100 .